Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
12 NEW November 21, 2022
Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia Patients

Antibody-Targeted Chemotherapy-Induced Remission and Stem Cell Transplantation Prolong Disease-Free Survival for Leukemia Patients

Fred Hutchinson Cancer Research Center Researcher Presents Study Results at the American Society of Hematology Meeting in San Francisco
News Releases - December 03, 2000
Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia

Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia

Fred Hutchinson Cancer Research Center Researcher Presents Updated Study Results at the American Society of Clinical Oncology Meeting in New Orleans
News Releases - May 21, 2000
Last Modified, April 02, 2020